Bezafibrate for the treatment of dyslipidemia in patients with coronary artery disease: 20-year mortality follow-up of the BIP randomized control trial

BACKGROUND: Recent data support the renewed interest in hypertriglyceridemia as a possible important therapeutic target for cardiovascular risk reduction. This study was designed to address the question of all-cause mortality during extended follow-up of the BIP trial in patients stratified by basel...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cardiovasc Diabetol
Auteurs principaux: Arbel, Yaron, Klempfner, Robert, Erez, Aharon, Goldenberg, Ilan, Benzekry, Sagit, Shlomo, Nir, Fisman, Enrique Z., Tenenbaum, Alexander
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2016
Sujets:
Original Investigation
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4722704/
https://ncbi.nlm.nih.gov/pubmed/26794137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-016-0332-6
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires